Company / Free Cash Flow
Tyra Biosciences, Inc. Free Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$70.4M
FY2024
5-year range
-$70.4M / -$8.1M
FY2020-FY2024
Trend
-38.4%
vs FY2023
Sector context
#88 of 194
Health Care
What the data says
At -$70M, Tyra Biosciences, Inc.'s free cash flow ranks #88 of 194 in the Health Care sector. Free Cash Flow has declined for 4 consecutive years, from -$8M in FY2020 to -$70M in FY2024.
Based on SEC 10-K filings.
-$70M in FY2024.
Declined from -$51M to -$70M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 194 in Health CareTop 45% of 194This company -$70.4M Sector average $470.6M
▼
-115.0% below sector average
Key checks
Key Insights
- Tyra Biosciences, Inc.'s free cash flow has declined for 4 consecutive years.
- In FY2024, free cash flow decreased 38.4% year-over-year.
- Ranks #88 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$70.4M | -38.4% |
| FY2023 | -$50.9M | -0.1% |
| FY2022 | -$50.8M | -108.3% |
| FY2021 | -$24.4M | -202.2% |
| FY2020 | -$8.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026